Document is current
Any future updates will be listed below
-
Authors
Vorenkamp, Kevin E. https://orcid.org/0000-0001-8416-7964
Lee, Gemayel
Lester, Denise D. https://orcid.org/0009-0003-3074-6057
Konda, Chaitanya https://orcid.org/0000-0002-1809-4346
Cohen, Steven P. https://orcid.org/0000-0001-5928-2127
Crosby, Nate D. https://orcid.org/0000-0001-6181-0806
Boggs, Joseph W. https://orcid.org/0000-0002-7973-7990
-
Funding
Funding for this research was provided by:
SPR Therapeutics
- License Information
-
More Information
Article History
Received: 24 March 2025
Accepted: 1 May 2025
First Online: 26 May 2025
Declarations
:
: Kevin E. Vorenkamp has nothing to disclose relevant to the present work. Gemayel Lee is a consultant to SPR Therapeutics. Denise D. Lester has received research funding paid to her institution by SPR Therapeutics unrelated to the present work. Chaitanya Konda has nothing to disclose relevant to the present work. Steven P. Cohen is a consultant to SPR Therapeutics. Nate D. Crosby and Joseph W. Boggs are employees of and hold stock options in SPR Therapeutics.
: The study was approved by the WIRB-Copernicus Group Institutional Review Board (WCG-IRB, #20242073) with a waiver of documentation of informed consent. The survey included a consent agreement that acknowledged the use of de-identified survey data for research purposes. The study was performed in accordance with relevant portions of the Declaration of Helsinki.
